Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
Clinical trial NCT06569823 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06569823
- Sponsor
- Dynavax Technologies Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2027-11-01
- Enrollment
- 764
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.